We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SXTP market cap is 2.96M. The company's latest EPS is USD -1.6392 and P/E is -0.79.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | |||
Total Revenue | 127k | 43k | 146k | 125k |
Operating Income | -1.52M | -1.9M | -1.33M | -4.19M |
Net Income | 4.18M | -2.01M | 430k | -4.17M |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 511k | 254k |
Operating Income | -1.75M | -5.16M |
Net Income | -6.18M | -3.77M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | |||
Total Assets | 9.15M | 7.78M | 8.38M | 4.33M |
Total Liabilities | 2.63M | 2.99M | 1.25M | 1.37M |
Total Equity | 6.52M | 4.8M | 7.13M | 2.96M |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 1.3M | 7.78M |
Total Liabilities | 25.45M | 2.99M |
Total Equity | -24.15M | 4.8M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | |||
Operating | -4.48M | -4.54M | -1.14M | -2.33M |
Investing | -49k | -116k | -10k | -140k |
Financing | 6.48M | 6.47M | 1.9M | 1.9M |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Operating | -1.01M | -4.54M |
Investing | -60k | -116k |
Financing | 1.22M | 6.47M |
Market Cap | 2.96M |
Price to Earnings Ratio | -0.79 |
Price to Sales Ratio | 11.66 |
Price to Cash Ratio | 1.38 |
Price to Book Ratio | 0.62 |
Dividend Yield | - |
Shares Outstanding | 2.3M |
Average Volume (1 week) | 512.72k |
Average Volume (1 Month) | 801.92k |
52 Week Change | -89.66% |
52 Week High | 13.5588 |
52 Week Low | 0.7015 |
Spread (Intraday) | 0.04 (2.99%) |
Company Name | 60 Degrees Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://60degreespharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions